THE USE OF MIGRAINE PROPHYLAXIS TREATMENT: ANALYSIS OF CLINICAL PRACTICE DATA FROM THE UNITED STATES, GERMANY, FRANCE, AND JAPAN

被引：1
|
作者：
Mutebi, A. [1 ]
Pike, J. [2 ]
Shah, N. [1 ]
Jackson, J. [3 ]
Cotton, S. [3 ]
Desai, P. R. [1 ]
Sapra, S. [1 ]
机构：
[1] Amgen Inc, Thousand Oaks, CA 91320 USA
[2] Adelphi Real World, Manchester, Lancs, England
[3] Adelphi Grp, Bollington, England
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 03期
关键词：
D O I：
10.1016/j.jval.2016.03.216
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PND55
引用
收藏
页码：A68 / A68
页数：1
相关论文
共 50 条
  • [1] FACTORS ASSOCIATED WITH A HISTORY OF FAILURE AND SWITCHING MIGRAINE PROPHYLAXIS TREATMENT: AN ANALYSIS OF CLINICAL PRACTICE DATA FROM THE UNITED STATES, GERMANY, FRANCE, AND JAPAN
    Pike, J.
    Mutebi, A.
    Shah, N.
    Jackson, J.
    Cotton, S.
    Desai, P. R.
    Sapra, S.
    VALUE IN HEALTH, 2016, 19 (03) : A68 - A68
  • [2] The Use of Migraine Prophylaxis Treatments in the United States of America: Analysis of Data From Clinical Practice
    Shah, N.
    Pike, J.
    Mutebi, A.
    Jackson, J.
    Cotton, S.
    Desai, P.
    Sapra, S.
    HEADACHE, 2016, 56 : 69 - 70
  • [3] MIGRAINE PROPHYLAXIS TREATMENT PATTERNS IN FRANCE: ANALYSIS OF DATA FROM CLINICAL PRACTICE
    Mutebi, A.
    Pike, J.
    Shah, N.
    Cotton, S.
    Desai, P.
    Sapra, S.
    CEPHALALGIA, 2016, 36 : 37 - 38
  • [4] MIGRAINE PROPHYLAXIS TREATMENT PATTERNS IN GERMANY: ANALYSIS OF DATA FROM CLINICAL PRACTICE
    Shah, N.
    Mutebi, A.
    Pike, J.
    Cotton, S.
    Desai, P.
    Sapra, S.
    CEPHALALGIA, 2016, 36 : 37 - 37
  • [5] MIGRAINE PROPHYLAXIS TREATMENT PATTERNS IN JAPAN: ANALYSIS OF DATA FROM CLINICAL PRACTICE
    Pike, J.
    Mutebi, A.
    Shah, N.
    Jackson, J.
    Cotton, S.
    Desai, P.
    Sapra, S.
    CEPHALALGIA, 2016, 36 : 36 - 37
  • [6] Unmet Need in Migraine Prophylaxis Treatment in the United States of America: Data from Clinical Practice
    Mutebi, A.
    Pike, J.
    Shah, N.
    Jackson, J.
    Cotton, S.
    Desai, P.
    Sapra, S.
    HEADACHE, 2016, 56 : 70 - 70
  • [7] CHARACTERIZING PATIENT-REPORTED HEALTH-RELATED QUALITY-OF-LIFE MEASURES AMONG USERS AND NON-USERS OF MIGRAINE PROPHYLAXIS TREATMENT: AN ANALYSIS OF CLINICAL PRACTICE DATA FROM THE UNITED STATES, GERMANY, FRANCE, AND JAPAN
    Shah, N.
    Mutebi, A.
    Pike, J.
    Jackson, J.
    Cotton, S.
    Desai, P. R.
    Sapra, S.
    VALUE IN HEALTH, 2016, 19 (03) : A68 - A68
  • [8] Current use of ROS1 testing in clinical practice in the United States, France, Germany, Italy, and Japan.
    De Richter, Pieter
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [9] Use of oncology drugs in Japan compared to France, Germany, Italy, Spain, Sweden, the United Kingdom, and the United States: A comparison based on data from 1999 to 2009
    Wilking, N. E.
    Hogberg, D.
    Jonsson, B.
    Koinuma, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [10] A comparative analysis of civilian technology strategies in France, Federal Republic of Germany, Japan, United Kingdom, and the United States
    Lederman, LL
    BARRIERS TO INTERNATIONAL TECHNOLOGY TRANSFER, 1996, 11 : 1 - 21
12345